期刊文献+

脾动脉栓塞术治疗慢性血小板减少性紫癜的远期疗效

脾动脉栓塞术治疗慢性血小板减少性紫癜的远期疗效
暂未订购
导出
摘要 目的探讨脾动脉栓塞术治疗慢性血小板减少性紫癜(Chronic idiopathic thrombocytopenic purpura)的远期疗效及术后的不良反应。方法选择35例药物治疗无效的慢性血小板减少性紫癜患者,采用seldinger技术对脾动脉进行栓塞,栓塞面积为60%~80%,并于术后定时复查血常规,观察其远期疗效(1~3年)及术后并发症。结果所有患者术后均有不同程度发热、脾区疼痛等栓塞后综合征表现,给予药物后缓解。追踪1年,有效率达87.5%,追踪2年,有效率达64.0%,追踪3年,有效率达46.2%。结论脾动脉栓塞术治疗慢性血小板减少性紫癜远期效果良好,并发症少,值得临床推广。 Objective This paper is to evaluate long term effect of splenic embolization in treatment of chronic idiopathic thrombocytopenic purpura and postoperative complications.Methods 35 cases of chronic idiopathic thrombocytopenic purpura failed by medicine were treated with embolizatin of splenic artery using seldinger technique.The embolization area of splenic artery was about 60%~80%.The blood routine examination was performed regularly and the effect for treatment was evaluated.Results All patients had post embolizatiou syndrome after operation to different extent,such as fever and pains in spleen and so on.The effective power is 87.5%,64.0% and 46.2% respectively in one,two and three years.Conclusion Splenic embolization is an ideal treatment for patients who contract chronic idiopathic thrombocytopenic purpura.Its complication is few.So it is worthy to be popularized.
出处 《当代医学》 2011年第22期6-7,共2页 Contemporary Medicine
关键词 脾动脉栓塞 慢性血小板减少性紫癜 远期疗效 Splenic artery embolization Chronic idiopathic thrombocytopenic purpura Prostecdtive efficacy
  • 相关文献

参考文献5

二级参考文献39

  • 1曹苇,朱琬莹,汪健,徐乃元,朱麟,陈易人.脾切除治疗特发性血小板减少性紫癜202例[J].中华普通外科杂志,2004,19(6):346-348. 被引量:17
  • 2杨小猛,刘仿,赵丹,陈群,肖红.特发性血小板减少性紫癜患儿血小板数与T细胞凋亡率的相关性分析[J].中华血液学杂志,2004,25(9):559-560. 被引量:7
  • 3郑传经.原发性血小板减少性紫癜治疗进展[J].中国实用儿科杂志,1994,9(4):207-209. 被引量:6
  • 4胡才校,杨德琪,钱申贤,陈虎,周健,俞巧平,孟海祥,王楚雄,金雄国.脾栓塞治疗特发性血小板减少性紫癜[J].中华血液学杂志,1995,16(3):152-153. 被引量:19
  • 5MAZZUCCONI MG,FAZI P,BERNASCONI S,et al.Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura:a GIMEMA ex perience[J].Bload,2007,109(4):111-116.
  • 6CHOUDHARY D.R,NAITHANI R,MAHAPATRA M,et al.Efficacy of cyclosporine as a single agent therapy in chronic idiopathic thrombocytopenic purpura[J].Haematologica,2008,93:61-62.
  • 7RYFFEL BD.Cyclosporine acellular activation:regulation of intracellular events by cyclosporine.Pharmcol Rev,1989,41:407-412.
  • 8KAPPERS-KLUNNE MC,VAN'T VEER MB.Cyclosporin A for the treatment of patients with chronic idiopathic thrombocytopenic purpura refractory to corticosteroids or splenectomy[J].Br.J Haematol.2001,114(1):121-125.
  • 9STAI R,PAGNO A,STIPA E,et al.Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura[J].Blood,2001,98:952.
  • 10FRANCESCO Z,MARTA L B,MARIA P,et al.Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpuram[J].Haematologica,2008,93:930-933.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部